X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 216,908 | 217,049 | 69,632 | 39,220 | 40,257 |
| Marketable Securities | 16,812 | 35,949 | 52,562 | 23,731 | 46,694 |
| Receivables | 1,113 | 573 | 1,606 | 1,865 | 1,174 |
| Inventories | 4,637 | 4,479 | 4,080 | 3,170 | 3,089 |
| TOTAL | $241,982 | $261,577 | $132,805 | $72,942 | $95,697 |
| Non-Current Assets | |||||
| PPE Net | 146 | 182 | 218 | 254 | 487 |
| Intangibles | 26,414 | 26,601 | 26,789 | 26,976 | 27,164 |
| Other Non-Current Assets | 1,739 | 2,101 | 3,743 | 4,996 | 6,665 |
| TOTAL | $28,299 | $28,884 | $30,750 | $32,226 | $34,316 |
| Total Assets | $270,281 | $290,461 | $163,555 | $105,168 | $130,013 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,073 | 5,696 | 5,053 | 7,709 | 11,115 |
| Accrued Expenses | 17,055 | 18,603 | 16,661 | 13,065 | 12,611 |
| TOTAL | $23,771 | $25,757 | $23,506 | $22,896 | $25,884 |
| Non-Current Liabilities | |||||
| Long Term Debt | 76,520 | 76,291 | 76,062 | 75,841 | 75,629 |
| Deferred Revenues | 910 | 464 | 592 | 754 | 855 |
| Other Non-Current Liabilities | 1,423 | 1,502 | 1,579 | 1,633 | 4,601 |
| TOTAL | $78,060 | $78,414 | $78,430 | $78,301 | $81,185 |
| Total Liabilities | $101,831 | $104,171 | $101,936 | $101,197 | $107,069 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,320 | 90,920 | 87,437 | 11,408 | 5,789 |
| Common Shares | 94 | 91 | 25 | 8 | 6 |
| Retained earnings | -614,795 | -594,554 | -570,629 | -540,814 | -515,073 |
| Other shareholders' equity | -122 | -109 | -118 | -138 | -128 |
| TOTAL | $168,450 | $186,290 | $61,619 | $3,971 | $22,944 |
| Total Liabilities And Equity | $270,281 | $290,461 | $163,555 | $105,168 | $130,013 |